The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices

Biosyent Inc down $0.01

Biosyent Inc closed lower Thursday, dropping $0.01 or 0.13% to $7.89. Over the last five days, shares have gained 1.15% and 12.71% year to date. Shares have underperformed the S&P TSX by 5.65% during the last year.

Key company metrics

  • Trailing P/E28.77×
  • P/E 1 year forward28.21×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS$0.27
Updated December 8 3:48 PM EST. Delayed by at least 15 minutes.

Latest Company News

View more News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue5444
Total other revenue--------
Total revenue5444
Gross profit4333
Total cost of revenue1111
Total operating expense3333
Selling / general / administrative2222
Research & development0000
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total0000
Operating income2111
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax2111
Income after tax1111
Income tax, total0000
Net income1111
Total adjustments to net income--------
Net income before extra. items1111
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1111
Inc. avail. to common incl. extra. items1111
Diluted net income1111
Dilution adjustment0000
Diluted weighted average shares15151414
Diluted EPS excluding extraordinary itemsvalue per share0.090.070.070.05
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.090.070.070.05